Real-world evidence was supposed to accelerate drug development. Instead, we've created definitional chaos—over 100 data vendors, inconsistent definitions, and studies that can't be compared.
Dr. Aaron Kamauu, CEO of Navidence and co-host of Real World Wednesday, explains why one missing diagnosis code can exclude 30% of your cohort, how GLP-1 eligibility criteria vary wildly between NHS and US guidelines, and what it means to document "the seven definitions you chose NOT to use."
A conversation about the unsexy infrastructure that makes evidence trustworthy.
Practical AI in Healthcare